13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
78 檔
31.4%
根据最新整理的 13F 季度数据集，Blue Owl Capital Holdings LP 于 Q4 2024 结束时的管理资产规模为 US$6.6亿。该机构在本季度申报了 78 档美股持仓，呈现出该时期的主要投资地图。
在 Q4 2024，Blue Owl Capital Holdings LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 12 个仓位并完全清仓 16 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Blue Owl Capital Holdings LP 的前 5 大核心持股（包含 NCDL, KVYO, PLRX 等）合计占整体申报市值的 31.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 15.99% | -3.32% | — | |
| 2 | KVYO | Klaviyo Inc-a | 股票-其他 | 10.49% | — | -9.97% | |
| 3 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 8.60% | -1.01% | EXIT | |
| 4 | OBDC | Blue Owl Capital CORP | 股票-金融 | 7.29% | -2.73% | — | |
| 5 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 6.81% | -3.07% | +17.90% | |
| 6 | CNDT | Conduent Inc | 股票-其他 | 5.36% | -0.62% | +67.27% | |
| 7 | TRML | Tourmaline Bio Inc | 股票-其他 | 5.16% | — | -29.47% | |
| 8 | ✓ | Engene Holdings Inc | 股票-其他 | 4.96% | -8.08% | EXIT | |
| 9 | EVCM | Evercommerce Inc | 股票-其他 | 4.26% | — | — | |
| 10 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 4.25% | -4.40% | +11.67% | |
| 11 | HLLY | Holley Inc | 股票-其他 | 2.13% | -1.81% | +17.56% | |
| 12 | ✓ | Acelyrin Inc | 股票-其他 | 2.06% | — | -0.36% | |
| 13 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 1.90% | -0.84% | — | |
| 14 | IRON | Disc Medicine Inc | 股票-其他 | 1.80% | — | -31.38% | |
| 15 | ✓ | Ikena Oncology Inc | 股票-其他 | 1.58% | — | — | |
| 16 | CNTX | Context Therapeutics Inc | 股票-其他 | 1.57% | -3.34% | +17.49% | |
| 17 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 1.41% | +1.00% | -20.91% | |
| 18 | TNGX | Tango Therapeutics Inc | 股票-其他 | 1.26% | — | — | |
| 19 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.17% | -0.78% | -27.57% | |
| 20 | EYPT | Eyepoint Inc | 股票-其他 | 1.17% | -1.52% | — | |
| 21 | RPTX | Repare Therapeutics Inc | 股票-其他 | 1.06% | — | +2.11% | |
| 22 | ETWOGBP | E2open Parent Holdings Inc | 股票-其他 | 1.04% | — | — | |
| 23 | CMPX | Compass Therapeutics Inc | 股票-其他 | 1.01% | -2.99% | +2.60% | |
| 24 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.91% | — | +97.85% | |
| 25 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 0.87% | — | -13.73% | |
| 26 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 0.76% | -0.91% | -26.53% | |
| 27 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 0.71% | -0.22% | — | |
| 28 | ✓ | Inozyme Pharma Inc | 股票-其他 | 0.71% | — | -3.57% | |
| 29 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.56% | — | -20.64% | |
| 30 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.41% | -0.07% | — | |
| 31 | ✓ | 股票-其他 | 0.39% | — | -8.73% | ||
| 32 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.34% | -0.58% | — | |
| 33 | GOCOQ | Gohealth Inc-class A | 股票-其他 | 0.26% | -0.02% | EXIT | |
| 34 | EPD | Enterprise Products Partners | 股票-能源 | 0.23% | -0.32% | EXIT | |
| 35 | OHI | Omega Healthcare Investors, Inc. | 股票-房地产 | 0.19% | — | — | |
| 36 | ✓ | 股票-其他 | 0.16% | — | — | ||
| 37 | ✓ | 股票-其他 | 0.16% | — | — | ||
| 38 | ✓ | Marblegate Acquisition Corp | 股票-其他 | 0.15% | — | — | |
| 39 | CMPS | Compass Pathways PLC | 股票-其他 | 0.14% | +0.96% | NEW | |
| 40 | GTLB | Gitlab Inc-cl A | 股票-科技 | 0.13% | — | — | |
| 41 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 0.11% | — | — | |
| 42 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.11% | -0.02% | — | |
| 43 | ✓ | Alpha Partners Technology Merg | 股票-其他 | 0.05% | — | — | |
| 44 | SLND-WS | Legato Merger CORP Ii -cw23 | 股票-其他 | 0.05% | -0.01% | — | |
| 45 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.05% | -0.10% | EXIT | |
| 46 | OPTX | Syntec Optics Holdings Inc | 股票-其他 | 0.03% | — | — | |
| 47 | AMODW | Insight Acquisition Co -cw23 | 股票-其他 | 0.02% | -0.01% | — | |
| 48 | PLMKW | Plum Acquisition Corp. IV | 股票-其他 | 0.02% | — | — | |
| 49 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.02% | -0.23% | EXIT | |
| 50 | ✓ | Satixfy Communications LTD | 股票-其他 | 0.02% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | CNDT | Conduent Inc | +2.6% | +67.27% | 加仓 |
| 2 | GOCOQ | Gohealth Inc-class A | +2.4% | — | 不变 |
| 3 | KVYO | Klaviyo Inc-a | +2.1% | -9.97% | 减仓 |
| 4 | NCDL | Nuveen Churchill Direct Lend | +2.1% | — | 不变 |
| 5 | PLRX | Pliant Therapeutics Inc | +1.9% | -7.82% | 减仓 |
| 6 | ELDN | Eledon Pharmaceuticals Inc | +1.9% | NEW | 新建仓 |
| 7 | OBDC | Blue Owl Capital CORP | +1.4% | — | 不变 |
| 8 | TNGX | Tango Therapeutics Inc | +1.2% | NEW | 新建仓 |
| 9 | EYPT | Eyepoint Inc | +1.2% | NEW | 新建仓 |
| 10 | ✓ | Engene Holdings Inc | +1% | +3.30% | 加仓 |
| 11 | EVCM | Evercommerce Inc | +0.9% | — | 不变 |
| 12 | PVLA | Palvella Therapeutics Inc | +0.7% | NEW | 新建仓 |
| 13 | HLLY | Holley Inc | +0.6% | +17.56% | 加仓 |
| 14 | SGMT | Sagimet Biosciences Inc-a | +0.5% | -20.91% | 减仓 |
| 15 | MRKR | Marker Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 16 | CGEM | Cullinan Therapeutics Inc | +0.2% | +17.90% | 加仓 |
| 17 | ✓ | +0.2% | NEW | 新建仓 | |
| 18 | CMPS | Compass Pathways PLC | +0.1% | NEW | 新建仓 |
| 19 | IRON | Disc Medicine Inc | +0.1% | -31.38% | 减仓 |
| 20 | CMPX | Compass Therapeutics Inc | 0% | +2.60% | 加仓 |
| 21 | ✓ | Adc Therapeutics SA | -0.1% | — | 不变 |
| 22 | MREO | Mereo Biopharma Group Pl-adr | -0.1% | -20.64% | 减仓 |
| 23 | ✓ | Engene Holdings Inc | -0.1% | -92.94% | 减仓 |
| 24 | TQQQ | ProShares UltraPro QQQ | -0.1% | EXIT | 清仓 |
| 25 | SYRS | Syros Pharmaceuticals Inc | -0.2% | EXIT | 清仓 |
| 26 | NU | Nu Holdings Ltd. | -0.2% | EXIT | 清仓 |
| 27 | BLND | Blend Labs Inc-a | -0.3% | EXIT | 清仓 |
| 28 | PAYO | Payoneer Global Inc | -0.3% | EXIT | 清仓 |
| 29 | ✓ | -0.3% | -8.73% | 减仓 | |
| 30 | ETWOGBP | E2open Parent Holdings Inc | -0.4% | — | 不变 |
| 31 | AQST | Aquestive Therapeutics Inc | -0.4% | -26.53% | 减仓 |
| 32 | ✓ | Inozyme Pharma Inc | -0.4% | -3.57% | 减仓 |
| 33 | IMVT | Immunovant Inc | -0.4% | EXIT | 清仓 |
| 34 | MLYS | Mineralys Therapeutics Inc | -0.5% | EXIT | 清仓 |
| 35 | KROS | Keros Therapeutics Inc | -0.5% | +97.85% | 加仓 |
| 36 | BRZE | Braze Inc-a | -0.5% | EXIT | 清仓 |
| 37 | VKTX | Viking Therapeutics Inc | -0.5% | EXIT | 清仓 |
| 38 | CNTX | Context Therapeutics Inc | -0.5% | +17.49% | 加仓 |
| 39 | GPCR | Structure Therapeutics Inc | -0.6% | EXIT | 清仓 |
| 40 | RARE | Ultragenyx Pharmaceutical In | -0.6% | -27.57% | 减仓 |
| 41 | ✓ | Acelyrin Inc | -0.7% | -0.36% | 减仓 |
| 42 | JANX | Janux Therapeutics Inc | -0.7% | EXIT | 清仓 |
| 43 | PYXS | Pyxis Oncology Inc | -0.8% | EXIT | 清仓 |
| 44 | STWD | Starwood Property Trust Inc | -0.9% | EXIT | 清仓 |
| 45 | CCC | Ccc Intelligent Solutions Ho | -1% | EXIT | 清仓 |
| 46 | ✓ | Lanzatech Global Inc | -1.1% | EXIT | 清仓 |
| 47 | LRMR | Larimar Therapeutics Inc | -1.1% | +11.67% | 加仓 |
| 48 | RPTX | Repare Therapeutics Inc | -1.2% | +2.11% | 加仓 |
| 49 | TRML | Tourmaline Bio Inc | -2.6% | -29.47% | 减仓 |
| 50 | TQQQ | Proshares Ultrapro Qqq | -4.5% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Blue Owl Capital Holdings LP 在 Q4 2024 季度的美股持仓总市值约为 US$6.6亿，共申报了 78 个公开持股仓位。
在 Q4 2024 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为：NCDL (16.0%)、KVYO (10.5%)、PLRX (8.6%)。其中最大持股仓位 NCDL 占据整体投资组合约 16.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
ELDN
市值: US$807.5万
本季最大获利了结 / 清仓标的
TQQQ
前期市值: US$2355.9万
在 Q4 2024 季度中，Blue Owl Capital Holdings LP 共进行了 44 项持仓异动，包含新建仓 7 个仓位、加仓 9 个仓位、减仓 12 个仓位以及清仓 16 个仓位。 其中最大新建仓标的为 ELDN。 本季清仓仓位包含 TQQQ。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。